Result-Analysis-Elite-Wealth
Result Analysis: ITC Ltd. Result Update Q2FY22
Particulars (In ₹. Cr) Q2FY22 Q1FY22 Q2FY21 QoQ % YoY%
Revenue from operation 14844 14240 13147 4.24% 12.91%
Other Income 468 447 582 4.70% -19.59%
Total Income 15312 14687 13729 4.26% 11.53%
Raw Material Expenses 4029 3893 3636 3.49% 10.81%
Other Expenses 6229 6327 5528 -1.55% 12.68%
Raw Material as percentage of revenue 27.14% 27.34% 27.66% -0.72% -1.86%
EBITDA 5486 4890 4,983 12.19% 10.09%
EBITDA Margin 36.96% 34.34% 37.90% 7.62% -2.49%
Profit After Tax 3,763 3,343 3,418 12.56% 10.09%
PATM (%) 25.35% 23.48% 26.00% 7.98% -2.49%
Basic EPS (in Rs. ) 3.02 2.66 2.74 13.53% 10.22%
Segment Revenue Q2FY22 Q1FY22 Q2FY21 QoQ % YoY%
FMCG
– Cigarettes 6220 5803 5628 7.19% 10.52%
– Others 4044 3731 3931 8.37% 2.88%
Total FMCG      10264 9534 9558 7.65% 7.38%
Hotels 311 134 88 132.69% 254.54%
Agri Business 2823 4110 3041 -31.31% -7.16%
Paperboards, Paper 1830 1583 1459 15.61% 25.44%
Others 736 680 580 8.23% 27.03%

Result Highlight: 

  • ITC Revenue rose 24% QoQ and 12.91% YoY to ₹ 14844 crore – in line with the estimates. Other income fall 19.59% YoY to ₹ 468 Crore.

  • EBITDA Margin was rose 250bps from 34.34% to 36.96% from last

  • Net profit rose 10.09% YoY to ₹3763 crore for the September quarter compared with ₹ 3418 crore in the same quarter last Reported strong operating Cash flow of ₹ 5821 crore in Q2.

  • EBITDA for the quarter came in at ₹ 5486 crore grew by 10.09% last year.

  • Cigarettes segment sales grew 10.52% y-o-y .cigarettes volume growth is around 9%.

  • Hotel Segment raw a sharp rebound as revenue increase 250x in this quarter compared to last year.

  • FMCG Segment EBITDA at 403 cr., up 35% sequentially and 82% over Q2 FY20. EBITDA Margins sustained at 10% in spite of unprecedented commodity inflation

  • Paperboards, Paper & Packaging Segment delivers strong performance; Segment Revenue up 25% y-o-y ̶ Paperboards volumes at record high.

Management commentary: 

  • Management said Shortage in availability of shipping containers/port congestions and inclement weather towards the end of the quarter delayed customer call-offs especially in agri segment

  • The project for the state-of-the-art facility to manufacture and export Nicotine & Nicotine derivative products being set up by the Company’s wholly owned subsidiary, ITC IndiVision Limited, is progressing. The facility is being geared to manufacture purest nicotine derivatives conforming to US and EU pharmacopoeia standards.

  • With easing of travel restrictions imposed during the second wave, domestic leisure segment and staycations witnessed an uptick during the quarter. Launched two new brands – ‘Storii’ and ‘Mementos’ – to expand footprint across the country through management contracts.

  • In cigarette segment Broad-based recovery witnessed across markets during the quarter; certain markets in Kerala and East remain relatively subdued.

  • On the FMCG revenue there was a disappointment as street was working with 7-8% revenue growth but it came at 3% which management said is due to higher base last year.

  • Management said there was robust growth in VAP segment; strong performance in exports on a high base notwithstanding logistical challenges. There was higher realisations, investments in pulp import substitution, cost-competitive fiber chain, sharper focus on operational efficiency has helped the company.

  • After significant disruptions in Q1, Cigarette volumes witnessed smart recovery with exit volumes at near preCovid levels cigarettes volume has seen faster recovery vs. first wave of the pandemic.

  OUTLOOK

ITC Q2FY22 result was mostly inline to the street expectation but the biggest disappointment was the FMCG revenue growth which came in at 3% which was lower than street expectation of 7-8%, Revenue grew 12.91% which was driven by good cigarette and Hotel business, EBITDA margin was flat compared to last year at 37%.and PAT was largely in line with street expectation. Company has manage margin well, as there raw material cost has moved up sharply, which is also expected to remain elevated going forward. In this quarter around 8% of total revenue come from digital market. ITC FMCG revenue was lower than expectation which management said is due to high base as there was stock pileup of hygienic and FMCG product in earlier quarter, while Paperboard Continued to See Strong YoY. IT segment of the company also saw good improvement and PAT margin has improved to 21.2% in first half. We believe margin may come under little pressure due to palm oil prices, crude prices and ocean freight cost, the biggest thing to see going forward is the FMCG volume growth. Government has also set up a panel which is going to give its recommendation on Tobacco Tax which may impact ITC cigarette business which is highest revenue and profit geneatator, ITC trades at at very steep discount to all other FMCG company and has underperform in this current rally but seeing its financial performance and strong free cash flow and very strong balance we believe this stock should perform well going forward.

At the CMP of ₹226, ITC is trading at PE multiple of 16x. Valuing the company at 20x FY23E EPS, we recommend buy on ITC at CMP of for the Target Price of ₹ 265.

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL